Mutations in the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) are found in more than 68% of WHO grade II and III gliomas and secondary glioblastomas (GBM) in human brain cancers [13–15]. Here, IDH1 is linked to glioma.